Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04312867 · ClinicalTrials.gov registry record · NA
Dating Violence Prevention Program Focusing on Middle School Boys
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT04312867: Completed NA study, sponsored by Rhode Island Hospital.
NCT04312867 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04312867, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
This study will test a web-based intervention to enhance emotion regulation skills and parent-son relationship communication to decrease adolescent boys' risk for dating violence involvement as well as attitudes supporting relationship aggression.
Primary Outcome
The Conflict in Adolescent Dating Relationships Inventory (CADRI), completed by dating teens, assesses verbal, emotional, physical, and sexual dating abuse perpetration and victimization with a current or recent dating partner. The CADRI has strong internal consistency (total α=.83) and 2-week test retest reliability, r=.68, p\<.01, as well as acceptable partner agreement (r=.64, p\<.01).
Interventions
- BEHAVIORAL Project STRONG
- BEHAVIORAL Health Promotion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2019-10-01 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
What the finished NCT04312867 record still lists
NCT04312867 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Project STRONG is the first listed.
NCT04312867 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04312867 about?
NCT04312867 is a clinical study titled "Dating Violence Prevention Program Focusing on Middle School Boys". This study will test a web-based intervention to enhance emotion regulation skills and parent-son relationship communication to decrease adolescent boys' risk for dating violence involvement as well as attitudes supporting relationship aggression.
What is the current status of trial NCT04312867?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2019-10-01. Estimated completion is 2025-05-31.
What interventions are being tested in trial NCT04312867?
The interventions under investigation include: Project STRONG (BEHAVIORAL), Health Promotion (BEHAVIORAL).
Who is sponsoring clinical trial NCT04312867?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04312867's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI